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Many G protein-coupled receptors (e.g. that of angio-
tensin II) activate phospholipase Cb, initially increasing
intracellular calcium and activating protein kinase C. In
the WB and GN4 rat liver epithelial cell lines, agonist-
induced calcium signals also stimulate tyrosine phos-
phorylation and subsequently increase the activity of
c-Jun N-terminal kinase (JNK). We have now purified
the major calcium-dependent tyrosine kinase (CADTK),
and by peptide and nucleic acid sequencing identified it
as a rat homologue of human PYK2. CADTK/PYK2 is
most closely related to p125FAK and both enzymes are
expressed in WB and GN4 cells. Angiotensin II, which
only slightly increases p125FAK tyrosine phosphoryla-
tion in GN4 cells, substantially increased CADTK tyro-
sine autophosphorylation and kinase activity. Agonists
for other G protein-coupled receptors (e.g. LPA), or
those increasing intracellular calcium (thapsigargin),
also stimulated CADTK. In comparing the two rat liver
cell lines, GN4 cells exhibited ; 5-fold greater angioten-
sin II- and thapsigargin-dependent CADTK activation
thanWBcells.AlthoughmaximalJNKactivationbystress-
dependent pathways (e.g. UV and anisomycin) was equiv-
alent in the two cell lines, calcium-dependent JNK activa-
tion was 5-fold greater in GN4, correlating with CADTK
activation. In contrast to JNK, the thapsigargin-depend-
ent calcium signal did not activatemitogen-activated pro-
tein kinase and Ang II-dependent mitogen-activated pro-
tein kinase activation was not correlated with CADTK
activation. Finally, while some stress-dependent activa-
tors of the JNK pathway (NaCl and sorbitol) stimulated
CADTK, others (anisomycin, UV, and TNFa) did not. In
summary, cells expressing CADTK/PYK2 appear to have
two alternative JNK activation pathways: one stress-
activated and the other calcium-dependent.
Multiple hormones, neurotransmitters, and immune effec-
tors rapidly raise intracellular calcium (Ca21), which in turn
regulates myriad cellular processes, including gene expression
and cell growth (1–3). The Ca21 signal acts, in part, by control-
ling serine and threonine protein phosphorylation through
multiple mechanisms, for example, by modulating Ca21/cal-
modulin dependent protein kinase (4) and protein kinase C (5,
6) activities. In the WB and GN4 rat liver epithelial cell lines
(7, 8) and in some other cells (9–14), hormones that activate
Gq-coupled receptors (e.g. angiotensin II, or Ang II)
1 stimulate
tyrosine phosphorylation in addition to the expected increases
in Ser/Thr phosphorylation. We have used rat liver cell lines to
demonstrate that hormones and other agonists that raise in-
tracellular Ca21 (e.g. thapsigargin) increase tyrosine phospho-
rylation, in part, by activating a soluble, Ca21-dependent tyro-
sine kinase (CADTK) (7, 8). Purification of the major
autophosphorylating tyrosine kinase from Ang II-treated rat
liver cells demonstrated a 115-kDa tyrosine kinase that could
be separated from another soluble tyrosine kinase present in
these cells, p125FAK (15).
We have also used rat liver cells to demonstrate that angio-
tensin II increases AP-1 binding activity in a protein kinase
C-independent manner (16). In investigating this phenomenon,
we showed that an intracellular Ca21 signal activates the c-Jun
N-terminal kinase (JNK) through a Ca21/calmodulin-inde-
pendent mechanism that was blocked by the tyrosine kinase
inhibitor, genistein (16). These results suggest that a novel
mechanism involving CADTK may be responsible for JNK ac-
tivation, in effect providing cells expressing CADTKwith a new
pathway of calcium-regulated gene expression. The present
report extends these studies by microsequencing and cDNA
cloning of the purified CADTK. These results identify CADTK
as the rat homologue of the recently cloned PYK2 (17). This
non-receptor tyrosine kinase is, by sequence, most closely re-
lated to p125FAK. However, CADTK/PYK2 and p125FAK clearly
exhibit different modes of activation. For example, in rat liver
epithelial cells CADTK appears to have a low activity state,
even in adherent cells, and is markedly stimulated by hormo-
nal and other agonists. In contrast, p125FAK is active in adher-
ent cells and is only minimally affected by hormonal stimula-
tion (see “Results” and Ref.15). The downstream signaling
consequences of CADTK/PYK2 also appear to diverge from
those of p125FAK, i.e. this report demonstrates that CADTK/
PYK2 activation is highly correlated with the stimulation of
c-Jun N-terminal kinase activity.
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MATERIALS AND METHODS
Purification and Peptide Sequencing of CADTK—GN4 cells (80
150-mm tissue culture plates) were treated with 1 mM Ang II for 1 min
and lysed as described (15). After centrifugation, lysate was passed over
an anti-Tyr(P) monoclonal antibody (PT66) column (Sigma), eluted with
10 mM phenylphosphate, and applied to an ATP-Sepharose column in
the presence of 50 mM Mg21 (15). After washing, ATP-bound, tyrosine-
phosphorylated proteins were eluted with 1 mM ATP, concentrated
using another anti-Tyr(P) affinity step, and subjected to SDS-polyacryl-
amide gel electrophoresis (SDS-PAGE) (15). For peptide sequencing,
purified CADTK was run on a 8–16% SDS-polyacrylamide gel (Novex,
San Diego, CA) and detected using Bio-Rad Copper Stain. After destain-
ing by chelation, the 115-kDa protein was reduced and pyridylethyl-
ated, and trypsinized in the gel (24 h at 37 °C). The peptide mixture was
extracted, and pooled extracts were dried, resuspended in 1% aqueous
acetic acid, loaded into a 1-mm capillary containing a small amount of
Poros R 2/H resin (about 100 nl of 50-mm particles), washed with 2 3 5
ml of 1% aqueous acetic acid, and eluted in 3 3 400 nl of 60:40 methanol:
water, 5% acetic acid as described elsewhere (18–20). The washings
were collected in a capillary and analyzed by electrospray ionization
mass spectrometry and tandem mass spectrometry. An ion spray volt-
age of 650 V sustained a liquid flow rate of ;20 nl/min. Mass spectra
were collected in either the MS or MS-MS modes, with several spectra
being averaged to improve signal/noise ratio. A total of six ions were
identified as representing peptides. Two of these, m/z 532 and 709,
were different charge states of the same peptide. There was also an
overlap of peptides with m/z 432 representing the octapeptide LGDF-
GLSR, and the ions at m/z 532 and 709 representing the overlapping
peptide NILVASPECVKLGDFGLSR. Altogether four regions of the
subsequently cloned protein were represented: residues 310–334, 554–
572, 672–687, and 989–998. One additional ion, m/z 758, represented
a tryptic peptide of trypsin itself.
Cloning of the CADTK cDNA from Rat Liver Epithelial Cells—
Trizol® (Life Technologies, Inc.) purified GN4 cell total RNA was
poly(A1)-selected and reverse-transcribed to create a probe. This probe
was used to screen a lZAP WB rat liver epithelial cell cDNA library.
The largest of 10 positive clones was a 3-kilobase cDNA beginning at
CADTK coding nucleotide base 1001 and extending to the 39-untrans-
lated region. polymerase chain reaction of reverse-transcribed GN4
poly(A1) RNA was used to complete the 59 coding region. The entire
coding region was sequenced and has been submitted to GenBank as
CADTK, accession number U69109.
CADTK Antiserum and Immunoprecipitation—The CADTK cDNA
was used to create a GST fusion protein encompassing amino acids
680–860. After purification using glutathione-agarose, rabbits were
injected with 500 mg of fusion protein in Freund’s complete adjuvant
followed by three boosts at 2-week intervals in Freund’s incomplete
adjuvant. The resultant antiserum recognizes CADTK and does not
cross-react with p125FAK. GN4 or WB cells (60 mm confluent dishes)
were treated, lysed, incubated with CADTK-specific antisera and pro-
tein A-agarose beads (Santa Cruz Biotechnology), and washed as de-
scribed (7, 8). In some experiments immunoprecipitation was performed
using anti-Tyr(P) monoclonal antibody (PT66). Immunoprecipitates
were subjected to 8% SDS-PAGE, transferred to Immobilon (Millipore),
and immunoblotted with either CADTK antiserum or anti-Tyr(P) mono-
clonal antibody (PT66) as described previously (7, 8).
c-Jun N-terminal and MAP Kinase Assays—WB and GN4 cells
(60-mm confluent dishes) were treated as indicated. For JNK kinase
activity assays, the cells were lysed and protein content determined. 50
mg of lysed cellular protein was incubated with GST-c-Jun (1–79) on
glutathione-agarose, precipitated, washed, and phosphorylated as de-
scribed previously (16). The reaction mixture, boiled in SDS sample
buffer, was subjected to 12% SDS-PAGE (16). Total JNK protein in WB
and GN4 cells was compared by using cell lysate from 60-mm confluent
dishes treated either with or without Ang II. Following immunoprecipi-
tation with anti-JNK antibody (generously provided by Dr. John Kyri-
akis), the precipitates were subjected to 10% SDS-PAGE, flanked by low
molecular weight prestained standards, transferred to nitrocellulose,
immunoblotted using the anti-JNK antibody, and developed with pro-
tein A-conjugated horseradish peroxidase and ECL reagent. The latter
decreased visualization of Ig heavy chain in the 50–55-kDa region.
MAP kinase activity state was assessed by immunoblotting of WB or
GN4 cell lysates run on 15% SDS gels using anti-Erk 1 antibody (k-23)
(Santa Cruz Biotechnology) (16). In other experiments, Erk-1 and Erk-2
were immunoprecipitated with anti-Erk 1 antibody (c-16) (Santa Cruz
Biotechnology) and used to phosphorylate myelin basic protein in the
presence of [g-32P]ATP. Phosphorylated myelin basic protein was as-
sessed by autoradiography after 15% SDS-PAGE (21).
RESULTS AND DISCUSSION
Identification of CADTK—To further study the role of Ca21-
dependent tyrosine phosphorylation, we purified activated
CADTK from Ang II-stimulated GN4 cells, taking advantage of
our previous finding that the activated enzyme was tyrosine-
phosphorylated (7, 8). Following a 60-s Ang II stimulation, GN4
cells were lysed and the enzyme purified by sequential anti-
phosphotyrosine antibody and ATP affinity chromatography
(Fig. 1A). Several large scale preparations were concentrated
by an additional anti-phosphotyrosine affinity step and sub-
jected to gel electrophoresis, in-gel trypsin digestion of the
purified CADTK, and analysis of the peptide mixture by Nano-
Electrospray on a tandem mass spectrometer. Sequence from
four peptides (amino acid residues 310–334, 554–572, 672–
687, and 989–998) was identified.
We next isolated the full-length cDNA encoding rat CADTK.
A WB cell cDNA library was screened, yielding a 3-kilobase
cDNA encoding nucleotide 1001 to the 39 end of the molecule.
The 59 region of the cDNA was obtained by polymerase chain
reaction amplification of GN4 cell first strand cDNA. The de-
duced amino acid sequence from the rat CADTK cDNA clone is
shown in Fig. 1B. Peptides sequenced from the purified protein
are noted in boxes. Sequence comparison indicated that the
cDNA was the rat homologue of a novel human non-receptor
protein-tyrosine kinase, PYK2 (17). In collaboration with Sima
Lev and Joseph Schlessinger, we determined that purified rat
CADTK was recognized on immunoblots by antiserum gener-
ated against the catalytic domain of human PYK2.2 The 115-
kDa protein was also recognized by specific antiserum raised to
a GST-CADTK fusion protein made using the rat CADTK
cDNA (see “Materials and Methods”). Thus, the cDNA clone
encodes the 115-kDa purified protein, as indicated by (i) com-
parison of sequenced peptides and predicted amino acid se-
quence, and (ii) recognition of the purified 115-kDa rat protein
by antiserum to two regions of CADTK/PYK2. Since the 115-
kDa protein was the predominant tyrosine kinase in Ang II-
treated GN4 cells (15), CADTK appears to be themajor calcium-
dependent tyrosine kinase in rat liver epithelial cells.
This newly identified rat tyrosine kinase, which we will refer
to by its functional name, CADTK, is closely related in se-
quence and domain structure to the focal adhesion kinase,
p125FAK (22, 23). CADTK/PYK2 cDNA clones were recently
isolated independently by two other groups using strategies to
detect p125FAK homologues. These were reported as cell adhe-
sion kinase b (CAKb) (24) and related adhesion focal tyrosine
kinase (RAFTK) (25). Our nucleotide sequence is identical to
that of rat CAKb with the exception of nucleotide 616 (C3 A).
The change predicts a Glu rather than an Ala in position 205.
A Glu is found in this position in human PYK2 (21), in mouse
RAFTK (25), and in mouse and human p125FAK. CADTK and
p125FAK exhibit approximately 45% amino acid identity (rat
CADTK versus mouse p125FAK) and 65% similarity. The ho-
mology is highest within the tyrosine kinase domain and the
latter part of the C terminus commonly referred to as the focal
adhesion targeting domain. Conversely, the identities are only
in the 25% range in the N terminus and in the proline-rich
domain residing between the catalytic domain and focal adhe-
sion targeting region. We and others have not found CADTK
expressed in commonly studied mouse fibroblast lines (Ref. 24
and data not shown). However, rat liver epithelial cells express
both p125FAK and CADTK, and it will be of interest to study the
2 S. Lev, J. Schlessinger, H. Yu, X. Li, R. Dy, L. Graves, and H. S.
Earp, unpublished results.
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function of these two homologous enzymes when they are ex-
pressed in the same cell.
Agonist-dependent CADTK Activation—CADTK was rapidly
(15 s) tyrosine-phosphorylated in GN4 cells treated with Ang II
(Fig. 2A) or thapsigargin (data not shown). Maximal phospho-
rylation is observed between 60 and 90 s. Pretreatment of cells
with BAPTA-AM prevented the Ang II-dependent rise in intra-
cellular Ca21 (8) and significantly attenuated CADTK auto-
phosphorylation in response to Ang II (Fig. 2A). As shown in
Fig. 2B, Ang II or another agonist that stimulates G protein-
coupled receptors, LPA, were at least twice as effective as
thapsigargin in activating CADTK. Thus, a calcium signal is a
significant, but perhaps not the sole, determinant of CADTK
activation.
We had previously shown Ca21-dependent JNK activation in
GN4 cells and had postulated that the involvement of CADTK
(16). Therefore, we tested whether agonists known to stimulate
JNK activity also stimulated CADTK autophosphorylation.
Hyperosmolarity (700 mM NaCl or 400 mM sorbitol) resulted in
CADTK activation (Fig. 2B). NaCl gave consistently greater
activation than sorbitol. The effect of hyperosmolarity on
CADTK tyrosine phosphorylation was less rapid than that of
Ang II and thapsigargin (data not shown), but with NaCl, the
maximal activation was similar to Ang II. However, other
agonists that stimulate JNK in GN4 cells (e.g. TNFa, UV
radiation, and anisomycin) failed to stimulate CADTK (Fig.
2B). Ang II and thapsigargin also stimulated CADTK immune
complex tyrosine kinase activity as measured by comparing
CADTK immunoprecipitates from control and agonist-treated
cells incubated with [g-32P]ATP, and poly(Glu4-Tyr) as a sub-
strate (8). Again, Ang II was approximately twice as effective as
thapsigargin at elevating CADTK tyrosine kinase activity
measured between 30 s and 5 min (data not shown).
Comparison of CADTK in GN4 and WB Cells—Previously we
showed that GN4 cells (derived by chemical transformation of
a normal rat liver epithelial line, WB; Ref. 26) exhibited 3–4
times the angiotensin II-dependent tyrosine phosphorylation of
its parent WB cell line (8). Using antiserum specific for rat
FIG. 1. Identification of rat calcium-dependent tyrosine kinase. A, a silver-stained 8% polyacrylamide gel of fractions following CADTK
purification. Lanes 1 and 2 represent the lysate and flow through fraction from the anti-Tyr(P) agarose column (approximately 0.00001% of the
total lysate and flow-through are shown). Lane 3 shows protein eluted by 10 mM phenylphosphate from anti-Tyr(P) agarose and lane 4 the fraction
eluted from ATP-Sepharose with 1 mM ATP. The ATP eluate was concentrated with a repeat anti-Tyr(P) monoclonal purification step (lane 6, the
flow-through of which is shown in lane 5). The kinase runs as a single band of 115 kDa (lane 6 represents 4% of the purified preparation). B, purified
CADTK was digested. Peptides were sequenced, and the full-length cDNA was cloned using rat liver epithelial cell RNA. The predicted amino acid
sequence is shown with the original sequenced peptides denoted by enclosure within a box.
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CADTK, we found that Ang II-treated confluent GN4 cells
consistently exhibited 4–5 fold more autophosphorylated
CADTK than similarly treated WB cells (Fig. 3). This approx-
imately 5-fold increase in CADTK tyrosine phosphorylation
was consistent whether WB and GN4 cells were compared by
immunoprecipitating CADTK and performing an anti-Tyr(P)
immunoblot (Fig. 3) or by immunoprecipitating with an anti-
Tyr(P) antibody and performing a CADTK immunoblot (data
not shown). Total CADTK protein expression was approxi-
mately 2–3-fold greater in confluent GN4 cells as determined
by immunoprecipitation of CADTK followed by a CADTK im-
munoblot (Fig. 3). Thus the increase in Ca21-dependent tyro-
sine phosphorylation observed in GN4 cells is secondary to both
increased expression of CADTK and additional increment in
the CADTK activation. Since neither Ca21 nor Ca21/calmodu-
lin appear to directly activate CADTK (8, 15, 17), exploration of
CADTK regulation by Ca21 may be aided by the difference in
activation between WB and GN4 cells.
Activation of CADTK: Correlation with JNK but Not MAP
Kinase Activation—In GN4 cells, Ang II stimulates MAP ki-
nase and JNK, as well as increasing AP-1 binding in a protein
kinase C-independent manner (16). Therefore, we examined
the correlation of CADTK activation with increases in AP-1
binding activity by comparing Ang II-dependent activation of
CADTK, MAP kinase, and JNK in GN4 and WB cells. Whereas
Ang II-dependent CADTK activity was 4–5 fold higher in GN4
cells (Fig. 3), Ang II-dependent MAP kinase activation was
similar in WB and GN4 cells (Fig. 4A). Furthermore, thapsigar-
gin, which is a potent, Ca21-dependent stimulator of JNK activ-
ity (see below), only minimally activated MAP kinase in GN4
cells as determined either by gel mobility shift or myelin basic
protein phosphorylation (Fig. 4, B and C, respectively). Thus, in
rat liver cells, MAP kinase activation was neither correlated
with CADTK activation nor substantially Ca21-dependent.
We have shown previously that Ang II and thapsigargin
significantly activate JNK in GN4 cells (16). We now show that
treatment with thapsigargin, Ang II, or EGF (which produces a
small PLCg-dependent Ca21 signal in these cells) stimulated
JNK activity 5–6-fold more effectively in GN4 than in WB cells
(Fig. 5A). This was not due to differential JNK expression; both
GN4 and WB cells exhibited similar, substantial increases in
JNK activity when treated with the protein synthesis inhibitor,
anisomycin (Fig. 5A). Furthermore, immunoblot analysis of
immunoprecipitated JNK protein showed nearly equal levels of
46- and 54-kDa JNK isoforms (lower and upper bands, respec-
tively; Fig. 5C) in GN4 and WB cells. An additional experiment
(Fig. 5B) confirms the exuberant JNK activation by thapsigar-
gin and Ang II in GN4 cells, but showed little difference in the
ability of hyperosmolarity (NaCl and sorbitol), UV exposure, or
anisomycin to stimulate JNK in the two cell types. Since ani-
somycin and UV failed to activate CADTK (Fig. 2B), it was not
surprising that these two agonists activate JNK similarly in
WB and GN4 cells. The UV and anisomycin results clearly
indicate that CADTK-independent pathways to JNK activation
exist in GN4 and WB cells. The fact that NaCl and sorbitol
stimulate CADTK does not a priori indicate that CADTK is the
only mechanism by which hyperosmolarity activates JNK. It is
likely that hyperosmolarity can maximally activate JNK in WB
cells through a stress pathway similar to that of UV and ani-
somycin, a pathway that does not vary significantly between
WB and GN4 cells.
The above results demonstrate that Ca21-dependent JNK
activation is well correlated with the 4–5-fold greater CADTK
activation in GN4 cells (above that seen in WB cells), whereas
FIG. 2. CADTK tyrosine phosphorylation in agonist-treated
cells. A, angiotensin II-stimulated CADTK tyrosine phosphorylation is
dependent in part on a calcium signal. Cells were pretreated with or
without 50 mM BAPTA-AM for 20 min prior to treatment with Ang II (1
mM) for the indicated times. Following lysis, CADTK was immunopre-
cipitated with anti-CADTK antiserum and subjected to SDS-PAGE,
transferred to Immobilon, and immunoblotted with monoclonal anti-
Tyr(P) antibody PT66. Tyrosine phosphorylation of CADTK was rapid
and was greatly attenuated in cells pretreated with the cell permeant
calcium chelator. B, agonist-induced CADTK tyrosine phosphorylation.
Confluent GN4 cells were treated for 90 s with Ang II (1 mM), thapsi-
gargin (2 mM), LPA (10 mg/ml) or for 5 min with NaCl (700 mM), sorbitol
(400 mM), TNFa (60 ng/ml), UV (100 J/m2), or anisomycin (10 mg/ml).
Cells were lysed, CADTK was immunoprecipitated, and its extent of
tyrosine phosphorylation was assessed by anti-Tyr(P) immunoblotting
as described above. Immunoblots were stripped and reprobed with
anti-CADTK antiserum to demonstrate equal CADTK immunoprecipi-
tation from each sample.
FIG. 3. Comparison of CADTK and its Ang II-dependent acti-
vation in WB and GN4 cells. Confluent plates (60 mM) of GN4 and
WB rat liver cells were treated with vehicle or Ang II (1 mM, 90 s). Cells
were lysed and equal amounts of cell protein immunoprecipitated with
monoclonal anti-Tyr(P) antibody PT66 (left panel) or anti-CADTK an-
tiserum (middle and right panels) as described under “Materials and
Methods.” Left panel was immunoblotted with PT66 to demonstrate the
Ang II-dependent Tyr(P) protein from WB and GN4 cells.Middle panel
was immunoblotted with PT66 to demonstrate the amount of tyrosine-
phosphorylated CADTK in Ang II-treated WB and GN4 cells. Right
panel was immunoblotted with anti-CADTK antiserum, demonstrating
the difference in CADTK protein immunoprecipitated from confluent
WB and GN4 cells. Confluent GN4 cells exhibited approximately 5-fold
greater CADTK tyrosine autophosphorylation and 2–3-fold more
CADTK protein.
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MAP kinase activation is not. Additional evidence supporting
this conclusion includes: (i) the small and temporally delayed
activation of CADTK caused by EGF correlates with a minimal
level of JNK activation in GN4 cells, which nonetheless exceeds
EGF-dependent JNK activation in WB cells (Fig. 5A), and (ii)
the substantial activation of CADTK by LPA (Fig. 2B) corre-
lates with substantial JNK activation in GN4 cells equivalent
to that of thapsigargin and Ang II (data not shown).
Activation of the JNK by hormones (16) and neurotransmit-
ters (27) demonstrates that there are hormone-dependent
pathways that may well be involved in physiological control of
gene expression in a cell type-specific manner; JNK is not just
involved in the stress response. The pathway from membrane
signal (hormone, TNFa, etc.) to JNK is not totally defined for
any agonist, including those that stimulate CADTK. However,
the work of others suggests that the JNK activation pathway
involves the small GTP-binding proteins, such as Rac and
Cdc42, PAK-like protein kinases, and MEKK (28–31). We have
demonstrated at least two pathways to JNK activation in GN4
cells, those correlated with CADTK activation (Ang II and
Ca21) and those not correlated (UV, TNFa, and anisomycin).
Additional preliminary studies support the two pathway model
in GN4 cells; cAMP and TPA significantly inhibit the Ang II
and thapsigargin-dependent pathways but not the stress-re-
lated pathway.3 Since cAMPandTPAdonot inhibit anisomycin-
dependent JNK activation, it is likely these agents inhibit the
putative CADTK3 JNK pathway prior to the JNKK/SEK step
(32–36). In GN4 cells, TNFa, UV, and anisomycin pathways do
not involve CADTK, and the pathway to JNK for these agonists
is presumably CADTK-independent.
It is intriguing that thapsigargin-dependent activation of
CADTK does not result in significant MAP kinase activation
(Fig. 2) in GN4 cells. In PC12 cells, intracellular Ca21 signals
and PYK2 overexpression did stimulate MAP kinase. Further-
more, expression of a dominant negative PYK2 blocked brady-
kinindependent MAP kinase activation (17). Our data may
suggest that key components coupling CADTK to MAP kinase
3 Li, X., Yu, H., He, Q., Gravea, L., and Earp, H. S., unpublished
results.
FIG. 4. MAP kinase activation by Ang II was similar in serum-
starved GN4 and WB cells and was only minimally activated by
thapsigargin. A, MAP kinase activity was assessed in WB and GN4
cells 5 min after stimulation with Ang II (1 mM), thapsigargin (2 mM),
and EGF (100 ng/ml). Cells were lysed and immunoprecipitated with
anti-Erk 1 antibody. The amount of myelin basic protein phosphoryla-
tion in treated and control cells was assessed as described under “Ma-
terials and Methods.” Ang II and EGF-dependent MAP kinase activa-
tion were similar in GN4 and WB cells. B and C, time-dependent
activation of MAP kinase was assessed in Ang II- and thapsigargin-
treated cells by examining the gel mobility shift of MAP kinase (Erks 1
and 2) by immunoblotting (B) or by assessing myelin basic protein
phosphorylation in the same samples (C). MAP kinase activation by
Ang II did not correlate with the 4–5-fold higher expression of CADTK
in GN4 cells.
FIG. 5. JNK activation is correlated with CADTK activation. A,
JNK kinase activity in GN4 and WB cells treated for 30 min with
vehicle, EGF (100 ng/ml), thapsigargin (2 mM), Ang II (1 mM), or aniso-
mycin (10 mg/ml) was assessed by measuring phosphorylation of GST
c-Jun (1–79) in lysates of serum-starved cells treated for the indicated
times as described under “Materials and Methods.” Calcium-dependent
agonists activated JNK 4–6 times more effectively in GN4 cells, which
exhibit .4–5 fold activation of CADTK. Anisomycin-dependent activa-
tion of JNK was equivalent in the two cell lines. B, in a separate
experiment, confluent GN4 and WB cells were incubated for 30 min
with thapsigargin (2 mM), Ang II (1 mM), NaCl (700 mM), Sorbitol (400
mM), UV (100 J/m2), and anisomycin (10 mg/ml). Cells were lysed and
JNK activity assessed as described above. The relative JNK activation
as reflected by GST c-Jun phosphorylation was at least 4–5-fold greater
in GN4 cells for Ca21-dependent agonists but was equal in the two cell
lines treated with agonists thought to be activated via the stress-de-
pendent pathway. C, the expression of 46- and 54-kDa JNK isoforms is
similar in WB and GN4 cells. Equal amounts of cell lysate were immu-
noprecipitated with anti-JNK antiserum from control or Ang II-treated
cells, subjected to SDS-PAGE and immunoblotted as described under
“Materials and Methods.” The 54-kDa isoform band is distorted by the
presence of the heavy chain from the immunoprecipitating antibody.
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are limiting in or absent from GN4 cells, explaining the pre-
ponderance of JNK (Fig. 5) as opposed to MAP kinase (Fig. 4)
activation following thapsigargin treatment. The large discrep-
ancy between Ca21-dependent MAP kinase and JNK activation
in GN4 cells serves to emphasize that the control of cell-type
specific gene expression by heterotrimeric G proteins may be
quite flexible. Specifically, whether a hormone activates JNK
or MAP kinase in a Ca21-dependent manner may be deter-
mined by (i) expression of CADTK or like enzymes, (ii) intact
pathways linking CADTK to JNK or MAP kinase, and (iii)
subtle modulation of either pathway by signaling cross-talk.
Acknowledgment—We thank Nancy Kaiser for expert preparation of
this manuscript.
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